Delivery Order SPE2DB25D9365-SPE2DB25FUJSQ
Award Date 9/23/25
Potential Completion Date 10/15/25
Potential Value $10K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,107.10 to DMS Pharmaceutical Group Inc. on September 9, 2025, for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. This delivery order represents a firm fixed-price contract with an ultimate completion date of September 30, 2025, and will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. This award, issued on September 23, 2025, with an ultimate completion date of October 15, 2025, represents a single delivery order without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 mL vials. The order was issued on September 11, 2025, with an ultimate completion date of October 2, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a delivery order valued at $25,106.30 to DMS Pharmaceutical Group Inc. for the supply of EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials on August 28, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 19, 2025, will be fulfilled from the vendor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a...
- The Defense Logistics Agency awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc. on September 11, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine formulation used for surgical site infiltration and nerve block anesthesia. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, will be delivered to Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on May 30, 2025, for EXPAREL (liposomal bupivacaine) 266 mg/20 mL vials. The contract carries a ceiling value of $5,021.26 and employs firm fixed-price pricing. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the DLA under the SPE2DB program,...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, valued at $15,063.78 with an ultimate completion date of October 9, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $30,127.56 to DMS Pharmaceutical Group Inc. for EXPAREL 266 mg/20 ml vials on September 2, 2025. This firm fixed-price delivery order is scheduled for completion by September 23, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, and the product will be supplied to support Department of Defense healthcare operations. DMS Pharmaceutical Group Inc., a woman-owned small business...
- The Defense Logistics Agency awarded a $25,106.30 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 31, 2025, for the supply of EXPAREL 266 mg/20 mL vials. This delivery order, which carries an ultimate completion date of August 21, 2025, represents a task order issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $500 million through November 2026. The award was made without set-aside designation, allowing DMS Pharmaceutical Group...
- The Defense Logistics Agency awarded a $15,063.78 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on June 18, 2025, for the supply of EXPAREL 266 mg/20 mL vials. EXPAREL is a liposomal bupivacaine local anesthetic used for infiltration and nerve block procedures in surgical settings. The delivery order, which carries an ultimate completion date of July 11, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical...